- Home
- PINC vs TVTX Comparison
PINC vs TVTX Comparison
Compare PINC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINC
- TVTX
- Stock Information
- Founded
- PINC 2013
- TVTX 2008
- Country
- PINC United States
- TVTX United States
- Employees
- PINC N/A
- TVTX N/A
- Industry
- PINC Other Consumer Services
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PINC Consumer Discretionary
- TVTX Health Care
- Exchange
- PINC Nasdaq
- TVTX Nasdaq
- Market Cap
- PINC 1.8B
- TVTX 1.5B
- IPO Year
- PINC 2013
- TVTX N/A
- Fundamental
- Price
- PINC $24.95
- TVTX $18.82
- Analyst Decision
- PINC Hold
- TVTX Strong Buy
- Analyst Count
- PINC 6
- TVTX 16
- Target Price
- PINC $22.20
- TVTX $33.40
- AVG Volume (30 Days)
- PINC 1.5M
- TVTX 1.5M
- Earning Date
- PINC 08-19-2025
- TVTX 08-06-2025
- Dividend Yield
- PINC 3.37%
- TVTX N/A
- EPS Growth
- PINC N/A
- TVTX N/A
- EPS
- PINC 0.63
- TVTX N/A
- Revenue
- PINC $1,260,388,000.00
- TVTX $333,865,000.00
- Revenue This Year
- PINC N/A
- TVTX $71.61
- Revenue Next Year
- PINC N/A
- TVTX $43.45
- P/E Ratio
- PINC $22.88
- TVTX N/A
- Revenue Growth
- PINC 7.16
- TVTX 87.94
- 52 Week Low
- PINC $17.23
- TVTX $8.46
- 52 Week High
- PINC $25.27
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- PINC 84.83
- TVTX 74.85
- Support Level
- PINC $21.50
- TVTX $15.60
- Resistance Level
- PINC $21.81
- TVTX $17.46
- Average True Range (ATR)
- PINC 0.57
- TVTX 0.83
- MACD
- PINC 0.38
- TVTX 0.26
- Stochastic Oscillator
- PINC 92.32
- TVTX 98.44
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.